Acasti Pharma (ACST) Insider Trading & Ownership $3.37 -0.03 (-0.88%) (As of 10/25/2024) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Acasti Pharma (NASDAQ:ACST) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage13.51%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$1.25 MNumber OfInsiders Selling(Last 3 Years)0 Get ACST Insider Trade Alerts Want to know when executives and insiders are buying or selling Acasti Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ACST Insider Buying and Selling by Quarter Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Acasti Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/25/2023Vimal KavuruDirectorBuy676,371$1.85$1,251,286.35 8/31/2023Donald OldsDirectorBuy381$2.05$781.05 (Data available from 1/1/2013 forward) ACST Insider Trading Activity - Frequently Asked Questions Who is on Acasti Pharma's Insider Roster? The list of insiders at Acasti Pharma includes Donald Olds, and Vimal Kavuru. Learn more on insiders at ACST. What percentage of Acasti Pharma stock is owned by insiders? 13.51% of Acasti Pharma stock is owned by insiders. Learn more on ACST's insider holdings. Which Acasti Pharma insiders have been buying company stock? The following insiders have purchased ACST shares in the last 24 months: Donald Olds ($781.05), and Vimal Kavuru ($1,251,286.35). How much insider buying is happening at Acasti Pharma? Insiders have purchased a total of 676,752 ACST shares in the last 24 months for a total of $1,252,067.40 bought. Acasti Pharma Key ExecutivesMr. Prashant Kohli (Age 52)CEO & Director Compensation: $358.41kMr. Robert J. DelAversano CPA (Age 52)Principal Financial & Accounting Officer Dr. R. Loch MacDonald M.D. (Age 62)Ph.D., Member of Scientific Advisory Board & Chief Medical Officer Mr. Amresh Kumar Ph.D. (Age 44)VP of Program Management Ms. Carrie D'Andrea (Age 52)VP of Clinical Operations More Insider Trading Tools from MarketBeat Related Companies Pyxis Oncology Insider Transactions Outlook Therapeutics Insider Transactions Ventyx Biosciences Insider Transactions Adverum Biotechnologies Insider Transactions Protalix BioTherapeutics Insider Transactions Context Therapeutics Insider Transactions Rani Therapeutics Insider Transactions Alto Neuroscience Insider Transactions Vaxart Insider Transactions Scilex Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:ACST) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acasti Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acasti Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACST Stock Alerts